Minimum Volume Standards for Surgical Care of Early-Stage Lung Cancer: A Cost-Effectiveness Analysis

Wednesday, December 21, 2022

Submitted by

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://doi.org/10.1016/j.athoracsur.2022.06.017

Author(s)

Melanie P. Subramanian, MD, MPHS, Zhizhou Yang, MD, Su-Hsin Chang, PhD, SM, Daniel Willis, MD, Jianrong Zhang, MD, Tara R. Semenkovich, MD, MPHS, Brendan T. Heiden, MD, MPHS, Benjamin D. Kozower, MD, MPH, Daniel Kreisel, MD, PhD, Bryan F. Meyers, MD, MPH, G. Alexander Patterson, MD, Ruben G. Nava, MD, and Varun Puri, MD, MSCI

This study aimed to determine the cost-effectiveness of receiving surgical resection for non-small cell lung cancer at hospitals that perform at least forty lung resections annually. An analysis was performed at hospitals stratified by Leapfrog standard, and concluded that although it is more costly, care at Leapfrog centers results in better ninety-day and five-year outcomes.